APO Research, Inc.

APO RESEARCH · REPORT

Poultry Medicine and Vaccines

Selected research

Market Analysis & Forecast

Global Poultry Medicine and Vaccines Market Analysis and Forecast 2026-2032

Market perspective

The global Poultry Medicine and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Poultry Medicine and Vaccines include Zoetis, Yebio, Vaksindo, Ringpu Biology, QYH Biotech, Merial, Merck Animal Health, Harbin Veterinary Research Institute and FATRO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Poultry Medicine and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Poultry Medicine and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Poultry Medicine and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Poultry Medicine and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Poultry Medicine and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Poultry Medicine and Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Poultry Medicine and Vaccines Segment by Company

Zoetis

Yebio

Vaksindo

Ringpu Biology

QYH Biotech

Merial

Merck Animal Health

Harbin Veterinary Research Institute

FATRO

Elanco (Lohmann)

DHN

ChengDu Tecbond

CEVA

CAVAC

Poultry Medicine and Vaccines Segment by Type

Medicine

Vaccines

Poultry Medicine and Vaccines Segment by Application

Chicken

Duck

Other

Poultry Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poultry Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poultry Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poultry Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Poultry Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Poultry Medicine and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poultry Medicine and Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Poultry Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medicine Major Player Table 3. Vaccines Major Player Table 4. Global Poultry Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Chicken Major Player Table 6. Duck Major Player Table 7. Other Major Player Table 8. Poultry Medicine and Vaccines Industry Trends Table 9. Poultry Medicine and Vaccines Industry Drivers Table 10. Poultry Medicine and Vaccines Industry Opportunities and Challenges Table 11. Poultry Medicine and Vaccines Industry Restraints Table 12. Global Poultry Medicine and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Poultry Medicine and Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Poultry Medicine and Vaccines Market Share by Region (2021-2026) Table 15. Global Poultry Medicine and Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Poultry Medicine and Vaccines Market Share by Region (2027-2032) Table 17. Global Poultry Medicine and Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Poultry Medicine and Vaccines Revenue Market Share by Players (2021-2026) Table 19. Global Poultry Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Poultry Medicine and Vaccines Key Players Headquarters & Area Served Table 21. Global Poultry Medicine and Vaccines Players, Product Type & Application Table 22. Global Poultry Medicine and Vaccines Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Poultry Medicine and Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Poultry Medicine and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Poultry Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Poultry Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Poultry Medicine and Vaccines Revenue Market Share by Type (2021-2026) Table 29. Global Poultry Medicine and Vaccines Revenue Market Share by Type (2027-2032) Table 30. Global Poultry Medicine and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Poultry Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Poultry Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Poultry Medicine and Vaccines Revenue Market Share by Application (2021-2026) Table 34. Global Poultry Medicine and Vaccines Revenue Market Share by Application (2027-2032) Table 35. Zoetis Company Information Table 36. Zoetis Business Overview Table 37. Zoetis Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Zoetis Poultry Medicine and Vaccines Product Portfolio Table 39. Zoetis Recent Development Table 40. Yebio Company Information Table 41. Yebio Business Overview Table 42. Yebio Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Yebio Poultry Medicine and Vaccines Product Portfolio Table 44. Yebio Recent Development Table 45. Vaksindo Company Information Table 46. Vaksindo Business Overview Table 47. Vaksindo Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Vaksindo Poultry Medicine and Vaccines Product Portfolio Table 49. Vaksindo Recent Development Table 50. Ringpu Biology Company Information Table 51. Ringpu Biology Business Overview Table 52. Ringpu Biology Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Ringpu Biology Poultry Medicine and Vaccines Product Portfolio Table 54. Ringpu Biology Recent Development Table 55. QYH Biotech Company Information Table 56. QYH Biotech Business Overview Table 57. QYH Biotech Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. QYH Biotech Poultry Medicine and Vaccines Product Portfolio Table 59. QYH Biotech Recent Development Table 60. Merial Company Information Table 61. Merial Business Overview Table 62. Merial Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merial Poultry Medicine and Vaccines Product Portfolio Table 64. Merial Recent Development Table 65. Merck Animal Health Company Information Table 66. Merck Animal Health Business Overview Table 67. Merck Animal Health Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Merck Animal Health Poultry Medicine and Vaccines Product Portfolio Table 69. Merck Animal Health Recent Development Table 70. Harbin Veterinary Research Institute Company Information Table 71. Harbin Veterinary Research Institute Business Overview Table 72. Harbin Veterinary Research Institute Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Harbin Veterinary Research Institute Poultry Medicine and Vaccines Product Portfolio Table 74. Harbin Veterinary Research Institute Recent Development Table 75. FATRO Company Information Table 76. FATRO Business Overview Table 77. FATRO Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. FATRO Poultry Medicine and Vaccines Product Portfolio Table 79. FATRO Recent Development Table 80. Elanco (Lohmann) Company Information Table 81. Elanco (Lohmann) Business Overview Table 82. Elanco (Lohmann) Poultry Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Elanco (Lohmann) Poultry Medicine and Vaccines Product Portfolio Table 84. Elanco (Lohmann) Recent Development Table 85. DHN Company Information Table 86. DHN Business Overview Table 87. DHN Poultry Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. DHN Poultry Medicine and Vaccines Product Portfolio Table 89. DHN Recent Development Table 90. ChengDu Tecbond Company Information Table 91. ChengDu Tecbond Business Overview Table 92. ChengDu Tecbond Poultry Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. ChengDu Tecbond Poultry Medicine and Vaccines Product Portfolio Table 94. ChengDu Tecbond Recent Development Table 95. CEVA Company Information Table 96. CEVA Business Overview Table 97. CEVA Poultry Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. CEVA Poultry Medicine and Vaccines Product Portfolio Table 99. CEVA Recent Development Table 100. CAVAC Company Information Table 101. CAVAC Business Overview Table 102. CAVAC Poultry Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. CAVAC Poultry Medicine and Vaccines Product Portfolio Table 104. CAVAC Recent Development Table 105. North America Poultry Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Poultry Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Poultry Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Poultry Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Poultry Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Poultry Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Poultry Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Poultry Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Poultry Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Poultry Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Poultry Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Poultry Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 119. China Poultry Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 120. China Poultry Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 121. China Poultry Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 122. China Poultry Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Poultry Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Poultry Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Poultry Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Poultry Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Poultry Medicine and Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Poultry Medicine and Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Poultry Medicine and Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Poultry Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Poultry Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Poultry Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Poultry Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Poultry Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Poultry Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Poultry Medicine and Vaccines Image Figure 2. Global Poultry Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poultry Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicine Image Figure 5. Vaccines Image Figure 6. Global Poultry Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Poultry Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Chicken Image Figure 9. Duck Image Figure 10. Other Image Figure 11. Global Poultry Medicine and Vaccines Market Size (US$ Million) & (2021-2032) Figure 12. Global Poultry Medicine and Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Poultry Medicine and Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Poultry Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Poultry Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Poultry Medicine and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Poultry Medicine and Vaccines Revenue Market Share by Type (2021-2032) Figure 19. Global Poultry Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Poultry Medicine and Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Poultry Medicine and Vaccines Revenue Market Share by Application (2021-2032) Figure 22. North America Poultry Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Poultry Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 24. North America Poultry Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 25. North America Poultry Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 26. United States Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Poultry Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Poultry Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 31. Europe Poultry Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 32. Europe Poultry Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 33. Germany Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Poultry Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Poultry Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 43. China Poultry Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 44. Asia Poultry Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Poultry Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 46. Asia Poultry Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 47. Asia Poultry Medicine and Vaccines Revenue Share by Region (2021-2032) Figure 48. Japan Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Poultry Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Poultry Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 56. SAMEA Poultry Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 57. SAMEA Poultry Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 58. Brazil Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Poultry Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Chicken
  • Duck
  • Other
Companies covered
  • Zoetis
  • Yebio
  • Vaksindo
  • Ringpu Biology
  • QYH Biotech
  • Merial
  • Merck Animal Health
  • Harbin Veterinary Research Institute
  • FATRO
  • Elanco (Lohmann)
  • DHN
  • ChengDu Tecbond
  • CEVA
  • CAVAC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Poultry Medicine and Vaccines Market by Type
  3. 1.2.1 Global Poultry Medicine and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medicine
  5. 1.2.3 Vaccines
  6. 1.3 Poultry Medicine and Vaccines Market by Application
  7. 1.3.1 Global Poultry Medicine and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Chicken
  9. 1.3.3 Duck
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Poultry Medicine and Vaccines Market Dynamics
  1. 2.1 Poultry Medicine and Vaccines Industry Trends
  2. 2.2 Poultry Medicine and Vaccines Industry Drivers
  3. 2.3 Poultry Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Poultry Medicine and Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Poultry Medicine and Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Poultry Medicine and Vaccines Growth Trends by Region
  3. 3.2.1 Global Poultry Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Poultry Medicine and Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Poultry Medicine and Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Poultry Medicine and Vaccines Revenue by Players
  2. 4.1.1 Global Poultry Medicine and Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Poultry Medicine and Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Poultry Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Poultry Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Poultry Medicine and Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Poultry Medicine and Vaccines Players, Product Type & Application
  8. 4.5 Global Poultry Medicine and Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Poultry Medicine and Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Poultry Medicine and Vaccines Tier 1, Tier 2, and Tier 3
5 Poultry Medicine and Vaccines Market Size by Type
  1. 5.1 Global Poultry Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Poultry Medicine and Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Poultry Medicine and Vaccines Revenue Market Share by Type (2021-2032)
6 Poultry Medicine and Vaccines Market Size by Application
  1. 6.1 Global Poultry Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Poultry Medicine and Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Poultry Medicine and Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Poultry Medicine and Vaccines Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Yebio
  8. 7.2.1 Yebio Company Information
  9. 7.2.2 Yebio Business Overview
  10. 7.2.3 Yebio Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Yebio Poultry Medicine and Vaccines Product Portfolio
  12. 7.2.5 Yebio Recent Developments
  13. 7.3 Vaksindo
  14. 7.3.1 Vaksindo Company Information
  15. 7.3.2 Vaksindo Business Overview
  16. 7.3.3 Vaksindo Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Vaksindo Poultry Medicine and Vaccines Product Portfolio
  18. 7.3.5 Vaksindo Recent Developments
  19. 7.4 Ringpu Biology
  20. 7.4.1 Ringpu Biology Company Information
  21. 7.4.2 Ringpu Biology Business Overview
  22. 7.4.3 Ringpu Biology Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ringpu Biology Poultry Medicine and Vaccines Product Portfolio
  24. 7.4.5 Ringpu Biology Recent Developments
  25. 7.5 QYH Biotech
  26. 7.5.1 QYH Biotech Company Information
  27. 7.5.2 QYH Biotech Business Overview
  28. 7.5.3 QYH Biotech Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 QYH Biotech Poultry Medicine and Vaccines Product Portfolio
  30. 7.5.5 QYH Biotech Recent Developments
  31. 7.6 Merial
  32. 7.6.1 Merial Company Information
  33. 7.6.2 Merial Business Overview
  34. 7.6.3 Merial Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merial Poultry Medicine and Vaccines Product Portfolio
  36. 7.6.5 Merial Recent Developments
  37. 7.7 Merck Animal Health
  38. 7.7.1 Merck Animal Health Company Information
  39. 7.7.2 Merck Animal Health Business Overview
  40. 7.7.3 Merck Animal Health Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merck Animal Health Poultry Medicine and Vaccines Product Portfolio
  42. 7.7.5 Merck Animal Health Recent Developments
  43. 7.8 Harbin Veterinary Research Institute
  44. 7.8.1 Harbin Veterinary Research Institute Company Information
  45. 7.8.2 Harbin Veterinary Research Institute Business Overview
  46. 7.8.3 Harbin Veterinary Research Institute Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Harbin Veterinary Research Institute Poultry Medicine and Vaccines Product Portfolio
  48. 7.8.5 Harbin Veterinary Research Institute Recent Developments
  49. 7.9 FATRO
  50. 7.9.1 FATRO Company Information
  51. 7.9.2 FATRO Business Overview
  52. 7.9.3 FATRO Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 FATRO Poultry Medicine and Vaccines Product Portfolio
  54. 7.9.5 FATRO Recent Developments
  55. 7.10 Elanco (Lohmann)
  56. 7.10.1 Elanco (Lohmann) Company Information
  57. 7.10.2 Elanco (Lohmann) Business Overview
  58. 7.10.3 Elanco (Lohmann) Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Elanco (Lohmann) Poultry Medicine and Vaccines Product Portfolio
  60. 7.10.5 Elanco (Lohmann) Recent Developments
  61. 7.11 DHN
  62. 7.11.1 DHN Company Information
  63. 7.11.2 DHN Business Overview
  64. 7.11.3 DHN Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 DHN Poultry Medicine and Vaccines Product Portfolio
  66. 7.11.5 DHN Recent Developments
  67. 7.12 ChengDu Tecbond
  68. 7.12.1 ChengDu Tecbond Company Information
  69. 7.12.2 ChengDu Tecbond Business Overview
  70. 7.12.3 ChengDu Tecbond Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 ChengDu Tecbond Poultry Medicine and Vaccines Product Portfolio
  72. 7.12.5 ChengDu Tecbond Recent Developments
  73. 7.13 CEVA
  74. 7.13.1 CEVA Company Information
  75. 7.13.2 CEVA Business Overview
  76. 7.13.3 CEVA Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CEVA Poultry Medicine and Vaccines Product Portfolio
  78. 7.13.5 CEVA Recent Developments
  79. 7.14 CAVAC
  80. 7.14.1 CAVAC Company Information
  81. 7.14.2 CAVAC Business Overview
  82. 7.14.3 CAVAC Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CAVAC Poultry Medicine and Vaccines Product Portfolio
  84. 7.14.5 CAVAC Recent Developments
8 North America
  1. 8.1 North America Poultry Medicine and Vaccines Revenue (2021-2032)
  2. 8.2 North America Poultry Medicine and Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Poultry Medicine and Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Poultry Medicine and Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Poultry Medicine and Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Poultry Medicine and Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Poultry Medicine and Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Poultry Medicine and Vaccines Revenue by Country
  11. 8.6.1 North America Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Poultry Medicine and Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Poultry Medicine and Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Poultry Medicine and Vaccines Revenue (2021-2032)
  2. 9.2 Europe Poultry Medicine and Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Poultry Medicine and Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Poultry Medicine and Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Poultry Medicine and Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Poultry Medicine and Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Poultry Medicine and Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Poultry Medicine and Vaccines Revenue by Country
  11. 9.6.1 Europe Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Poultry Medicine and Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Poultry Medicine and Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Poultry Medicine and Vaccines Revenue (2021-2032)
  2. 10.2 China Poultry Medicine and Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Poultry Medicine and Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Poultry Medicine and Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Poultry Medicine and Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Poultry Medicine and Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Poultry Medicine and Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Poultry Medicine and Vaccines Revenue (2021-2032)
  2. 11.2 Asia Poultry Medicine and Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Poultry Medicine and Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Poultry Medicine and Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Poultry Medicine and Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Poultry Medicine and Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Poultry Medicine and Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Poultry Medicine and Vaccines Revenue by Country
  11. 11.6.1 Asia Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Poultry Medicine and Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Poultry Medicine and Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Poultry Medicine and Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Poultry Medicine and Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Poultry Medicine and Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Poultry Medicine and Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Poultry Medicine and Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Poultry Medicine and Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Poultry Medicine and Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Poultry Medicine and Vaccines Revenue by Country
  11. 12.6.1 SAMEA Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Poultry Medicine and Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Poultry Medicine and Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.